RT Book, Section A1 Lee, Charlotte A1 Dec, G. William A2 Fuster, Valentin A2 Narula, Jagat A2 Vaishnava, Prashant A2 Leon, Martin B. A2 Callans, David J. A2 Rumsfeld, John S. A2 Poppas, Athena SR Print(0) ID 1202454909 T1 Obstructive and Nonobstructive Coronary Disease in Heart Failure T2 Fuster and Hurst's The Heart, 15e YR 2022 FD 2022 PB McGraw-Hill Education PP New York, NY SN 9781264257560 LK accesscardiology.mhmedical.com/content.aspx?aid=1202454909 RD 2024/10/07 AB Content UpdateStudy Summary: REVIVED-BCIS2The Revascularization for Ischemic Ventricular Dysfunction (REVIVED-BCIS2) trial was a prospective, multicenter, open-label trial that randomized 700 patients with left ventricular dysfunction (defined as left ventricular ejection fraction (LVEF) of ≤35%), extensive coronary artery disease amenable to percutaneous coronary intervention (PCI), and demonstrable myocardial viability to a strategy of optimal medical therapy (OMT) plus PCI (n=347) or OMT alone (n = 353). Read More